(Press-News.org) This news release is available in German.
"When water boils, its molecules are released as vapor. We call this change of the physical state of matter a phase transition," explains Sebastian Diehl from the Institute of Theoretical Physics at the University of Innsbruck. Together with his colleagues from the Institute for Experimental Physics and the theorist Markus Mueller from the Complutense University of Madrid, he studied the transition between two quantum mechanical orders in a way never before observed. The quantum physicists in Innsbruck use a new device for the experiment, which is currently considered to be one of the most promising developments in quantum physics: a quantum simulator. It is based on a small-scale quantum computer and can simulate physical phenomena a classical computer cannot investigate efficiently. "Such a quantum simulator allows us to experimentally study quantum phenomena in many-body systems that are coupled to their environment," explain experimental physicists Philipp Schindler and Thomas Monz.
Observing the competition
With just a few trapped ions the scientists simulate the complex physical processes of quantum mechanical phase transitions. To achieve this, they have to manipulate and control the particles with high accuracy; the experimental physicists in Innsbruck are world leaders in this field. "For this experiment we use a programmable quantum simulator with up to five ions," says Philipp Schindler. One of the particles is used as a means to couple the system to the classical environment in a controlled manner. The other ions are used for carrying out quantum operations. "We call this an open quantum simulator. Usually we want to suppress this coupling because it destroys the fragile quantum effects in the system. Here, however, we use it to bring order into the quantum mechanical system," explains Schindler. "In our specific case, we engineer a classical environment, which generates dissipative dynamics, leading to fragile long-range quantum mechanical correlations between distant particles." In the following step, this dynamics is then set in competition with a different type of interactions, which interrupts the dynamics that create the quantum mechanical order. "By doing this, we are able to observe how the competition between these two processes takes place and what precisely occurs right at the transition between two distinct orders of matter," explains theoretical physicist Sebastian Diehl.
Error reduction
The experiment demands an enormous degree of precision, which requires immediate error corrections to be able to simulate the physical processes correctly. Since a comprehensive error correction, as developed for quantum computers, involves considerable resource overheads, the physicists in Innsbruck chose another promising alternative path. They identified the most important sources of error occurring during the simulation and specifically targeted them. Schindler is convinced: "This way of error reduction will surely set an example for other experiments. While general quantum error correction remains a long-term goal, we may be able to successfully use this type of error correction a lot sooner for reliable quantum simulation of larger systems," adds Markus Mueller.
Interweaving theory with experiment
Such an experimental study of the nature of quantum mechanical phase transitions is internationally unique. It was only possible because advanced experimental know-how was successfully combined with theoretical research, which was carried out in close collaboration between physicists from Innsbruck and Madrid. "This link between theoretical and experimental physicists who work closely together, and in Innsbruck under one roof, is possible in very few places. It is also one of the great strengths of quantum physics research carried out in Innsbruck. And this research, once again, led us into an area of physics that hadn't been explored before," says Rainer Blatt. "In this experiment the physics of many-body systems is successfully simulated with a few trapped ions. This clearly shows the potential and the possibilities of quantum simulation," adds Peter Zoller.
INFORMATION:
Competition in the quantum world
2013-05-20
ELSE PRESS RELEASES FROM THIS DATE:
Diabetes drug tested in Parkinson's disease patients
2013-05-20
Parkinson's disease (PD) is a degenerative neurological disorder marked by a progressive loss of motor control. Despite intensive research, there are currently no approved therapies that have been demonstrated to alter the progression of the disease. In this issue of the Journal of Clinical Investigation, Dr. Thomas Foltynie and colleagues at the National Hospital for Neurology and Neurosurgery in London investigated the use of a drug approved for diabetes care, Exenatide, in PD patients. PD patients were divided into two groups: 20 patients received Exenatide injections ...
Women with severe injuries are less likely than men to be treated in a trauma center
2013-05-20
ATS 2013, PHILADELPHIA - Women are less likely than men to receive care in a trauma center after severe injury, according to a new study of almost 100,000 Canadian patients.
"Gender-based disparities in access to healthcare services in general have been recognized for some time and evidence is emerging that these disparities extend to the treatment of severe injuries in trauma centers," says lead author Andrea Hill. MSc, PhD, a post-doctoral fellow at Sunnybrook Health Sciences Centre and the University of Toronto in Ontario, Canada. "Our study confirms and expands on ...
Source of infection affects hospital mortality in septic shock patients in the ICU
2013-05-20
In ICU patients who have septic shock, the anatomic source of infection has a strong effect on the chances of survival, according to a new study from researchers in Canada.
"Understanding the local infection source in patients with septic shock may influence treatment strategies and clinical outcomes," said researcher Peter Dodek, MD MHSc, professor of critical care medicine at the University of British Columbia in Vancouver. "Accordingly, we examined the relationship between anatomic source of infection and hospital mortality in nearly 8,000 patients who had septic ...
New study identifies risk factors for depression among COPD patients
2013-05-20
ATS 2013, PHILADELPHIA ─ Patients suffering from chronic obstructive pulmonary disease (COPD) typically suffer from depression more frequently than those without COPD, resulting in higher levels of disability and illness and increasing the overall healthcare burden for the COPD population. Now, a study from researchers in Argentina indicates female COPD patients and patients who experience significant shortness of breath may have the greatest risk for developing depression.
The results of the study will be presented at the ATS 2013 International Conference.
"About ...
Stress test may help predict increased mortality risk in sleep apnea patients
2013-05-20
ATS 2013, PHILADELPHIA – Many studies have shown that men and women who suffer from obstructive sleep apnea (OSA) - a disorder that causes breathing to halt intermittently during sleep – have a higher mortality rate than those who do not have the disorder. Now, a study from researchers at the Cleveland Clinic shows that OSA patients who also have poor functional capacity have an even greater risk of mortality and suggests that an assessment of functional capacity in this population can help physicians identify patients most at risk for death.
The results of the study ...
Metabolic biomarkers can predict mortality in the ICU
2013-05-20
ATS 2013, PHILADELPHIA – A metabolic profile of intensive care unit (ICU) patients based on biomarkers of four metabolites can be used to accurately predict mortality, according to a new study.
"Existing models for predicting mortality in the ICU may not always be accurate and they can also be cumbersome to use," said researcher Angela J. Rogers MD, MPH, Instructor in Medicine at Channing Laboratory, Brigham and Women's Hospital, Harvard Medical School in Boston. "Levels of lactate, a metabolite from the carbohydrate pathway, are an established biomarker for ICU mortality. ...
Food laboratory accuracy remains a concern
2013-05-20
Food microbiology laboratories continue to submit false negative results and false positive results on a routine basis. A retrospective study of nearly 40,000 proficiency test results over the past 14 years, presented today at the 113th General Meeting of the American Society for Microbiology, examined the ability of food laboratories to detect or rule out the presence of Escherichia coli O157:H7, Salmonella, Listeria monocytogenes, and Campylobacter.
"There is concern when laboratories report that pathogens are not found in a food sample, when in fact they are there," ...
Pharmaceutical advances offer new options for health outcomes
2013-05-20
Orlando, FL (May 20, 2013) — Research presented at Digestive Disease Week® (DDW) explores pharmaceutical advances for treating irritable bowel syndrome with diarrhea (IBS-D) and hepatitis C.
An international study holds promising results for patients suffering from IBS-D. In the phase II study, researchers found that the drug ibodutant significantly improved symptoms in more than 50 percent of the individuals treated.
"While there's been a lot of progress in medicines for IBS with constipation, we haven't seen the same in IBS with diarrhea," said Jan Tack, MD, professor ...
Mayo Clinic: Inflammatory bowel disease raises risk of melanoma
2013-05-20
ROCHESTER, Minn. — Patients with inflammatory bowel disease (IBD) are at higher risk of melanoma, a form of skin cancer, report researchers at Mayo Clinic. Researchers found that IBD is associated with a 37 percent greater risk for the disease. The findings were presented at the Digestive Disease Week 2013 conference in Orlando, Fla.
More than 1.5 million Americans have Crohn's disease or ulcerative colitis (UC), the most common forms of inflammatory bowel disease. Both conditions inflame the lining of the intestine, leading to bouts of watery diarrhea, rectal bleeding, ...
Team finds mechanism linking key inflammatory marker to cancer
2013-05-20
CHAMPAIGN, Ill. — In a new study described in the journal Oncogene, researchers reveal how a key player in cell growth, immunity and the inflammatory response can be transformed into a primary contributor to tumor growth.
Scientists call this Jekyll-and-Hyde molecule NF-kappa B. In healthy cells, it is a powerful "first responder," a vital part of the body's immune and inflammatory responses. It spends most of its life in the cell's cytoplasm, quietly awaiting orders. But when extracellular signals – of a viral or bacterial invasion, for example – set off chemical alarms, ...